652 related articles for article (PubMed ID: 25447326)
1. Update on ankylosing spondylitis: current concepts in pathogenesis.
Smith JA
Curr Allergy Asthma Rep; 2015 Jan; 15(1):489. PubMed ID: 25447326
[TBL] [Abstract][Full Text] [Related]
2. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates.
Babaie F; Hasankhani M; Mohammadi H; Safarzadeh E; Rezaiemanesh A; Salimi R; Baradaran B; Babaloo Z
Immunol Lett; 2018 Apr; 196():52-62. PubMed ID: 29409751
[TBL] [Abstract][Full Text] [Related]
3. IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
Baeten D; Adamopoulos IE
Front Immunol; 2020; 11():623874. PubMed ID: 33679714
[TBL] [Abstract][Full Text] [Related]
4. Genetics of ankylosing spondylitis and rheumatoid arthritis: where are we at currently, and how do they compare?
Maksymowych WP; Brown MA
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S20-5. PubMed ID: 19822041
[TBL] [Abstract][Full Text] [Related]
5. The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.
Jethwa H; Bowness P
Clin Exp Immunol; 2016 Jan; 183(1):30-6. PubMed ID: 26080615
[TBL] [Abstract][Full Text] [Related]
6. Progress in our understanding of the pathogenesis of ankylosing spondylitis.
Simone D; Al Mossawi MH; Bowness P
Rheumatology (Oxford); 2018 Aug; 57(suppl_6):vi4-vi9. PubMed ID: 30445483
[TBL] [Abstract][Full Text] [Related]
7. Update on the role of Interleukin 17 in rheumatologic autoimmune diseases.
Konya C; Paz Z; Apostolidis SA; Tsokos GC
Cytokine; 2015 Oct; 75(2):207-15. PubMed ID: 26028353
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17 targeted therapies in axial spondyloarthritis.
Wendling D
Immunotherapy; 2015; 7(11):1125-8. PubMed ID: 26513376
[No Abstract] [Full Text] [Related]
9. The genetic basis of ankylosing spondylitis.
Reveille JD
Curr Opin Rheumatol; 2006 Jul; 18(4):332-41. PubMed ID: 16763451
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of ankylosing spondylitis - recent advances and future directions.
Ranganathan V; Gracey E; Brown MA; Inman RD; Haroon N
Nat Rev Rheumatol; 2017 Jun; 13(6):359-367. PubMed ID: 28446810
[TBL] [Abstract][Full Text] [Related]
11. CD4 and CD8 T cell response to the rHSP60 from Klebsiella pneumoniae in peripheral blood mononuclear cells from patients with ankylosing spondylitis.
Zambrano-Zaragoza F; García-Latorre E; Domínguez-López ML; Cancino-Díaz ME; Burgos-Vargas R; Jiménez-Zamudio L
Rev Invest Clin; 2005; 57(4):555-62. PubMed ID: 16315640
[TBL] [Abstract][Full Text] [Related]
12. The interaction between host genetics and the microbiome in the pathogenesis of spondyloarthropathies.
Asquith M; Rosenbaum JT
Curr Opin Rheumatol; 2016 Jul; 28(4):405-12. PubMed ID: 27152700
[TBL] [Abstract][Full Text] [Related]
13. The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis.
Brionez TF; Reveille JD
Curr Opin Rheumatol; 2008 Jul; 20(4):384-91. PubMed ID: 18525349
[TBL] [Abstract][Full Text] [Related]
14. Genetics and genomics of ankylosing spondylitis.
Thomas GP; Brown MA
Immunol Rev; 2010 Jan; 233(1):162-80. PubMed ID: 20192999
[TBL] [Abstract][Full Text] [Related]
15. Progress in the genetics of ankylosing spondylitis.
Brown MA
Brief Funct Genomics; 2011 Sep; 10(5):249-57. PubMed ID: 21965815
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of ankylosing spondylitis-mechanisms of disease manifestation and chronicity].
Märker-Hermann E; Frauendorf E; Zeidler H; Sieper J
Z Rheumatol; 2004 Jun; 63(3):187-92. PubMed ID: 15224221
[TBL] [Abstract][Full Text] [Related]
17. Role of innate immune system in the pathogenesis of ankylosing spondylitis.
Vanaki N; Aslani S; Jamshidi A; Mahmoudi M
Biomed Pharmacother; 2018 Sep; 105():130-143. PubMed ID: 29852390
[TBL] [Abstract][Full Text] [Related]
18. Old and new HLA associations with ankylosing spondylitis.
Díaz-Peña R; López-Vázquez A; López-Larrea C
Tissue Antigens; 2012 Sep; 80(3):205-13. PubMed ID: 22881057
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.
Kenna TJ; Davidson SI; Duan R; Bradbury LA; McFarlane J; Smith M; Weedon H; Street S; Thomas R; Thomas GP; Brown MA
Arthritis Rheum; 2012 May; 64(5):1420-9. PubMed ID: 22144400
[TBL] [Abstract][Full Text] [Related]
20. Solving the pathogenesis of ankylosing spondylitis.
Brown MA
Clin Immunol; 2018 Jan; 186():46-50. PubMed ID: 28736277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
